| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-related differences in drug-induced liver injury: a retrospective single-center study from a large liver disease specialty hospital in China, 2002–2022
|
Yu, Simiao
|
|
|
18 |
4 |
p. 1202-1213
|
artikel
|
| 2 |
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
|
Zhang, Huai
|
|
|
18 |
4 |
p. 1178-1201
|
artikel
|
| 3 |
Chinese guidelines on the management of ascites in cirrhosis
|
Xu, Xiaoyuan
|
|
|
18 |
4 |
p. 1071-1089
|
artikel
|
| 4 |
Clinical evaluation of droplet digital pcr for suspected ascites infection in patients with liver cirrhosis
|
Han, Jie
|
|
|
18 |
4 |
p. 1249-1260
|
artikel
|
| 5 |
Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis
|
Engel, Bastian
|
|
|
18 |
4 |
p. 1214-1226
|
artikel
|
| 6 |
Efficacy and safety of precision-guided transjugular extrahepatic portosystemic shunt (TEPS) in the management of cavernous transformation of the portal vein with portal hypertension: a case series
|
Zhang, Liu
|
|
|
18 |
4 |
p. 1227-1237
|
artikel
|
| 7 |
Efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma: a propensity score-matched retrospective cohort study
|
Li, He
|
|
|
18 |
4 |
p. 1271-1285
|
artikel
|
| 8 |
HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B
|
Feng, Zhiqian
|
|
|
18 |
4 |
p. 1122-1134
|
artikel
|
| 9 |
Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis
|
Li, Yangyang
|
|
|
18 |
4 |
p. 1286-1298
|
artikel
|
| 10 |
Hepatic-associated vascular morphological assessment to predict overt hepatic encephalopathy before TIPS: a multicenter study
|
Chen, Xiaoqiong
|
|
|
18 |
4 |
p. 1238-1248
|
artikel
|
| 11 |
Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome
|
Oshi, Masanori
|
|
|
18 |
4 |
p. 1299-1309
|
artikel
|
| 12 |
Inflammation of the liver, HCC development and HCC establishment
|
Kanda, Tatsuo
|
|
|
18 |
4 |
p. 1090-1092
|
artikel
|
| 13 |
Is TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors superior to TACE plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: the debate continues
|
Yang, Shiye
|
|
|
18 |
4 |
p. 1336-1337
|
artikel
|
| 14 |
Metabolic dysfunction-associated fatty liver disease and heavy alcohol consumption increase mortality:A nationwide study
|
Cho, So Hyun
|
|
|
18 |
4 |
p. 1168-1177
|
artikel
|
| 15 |
Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial
|
Ranjan, Abhijeet
|
|
|
18 |
4 |
p. 1261-1270
|
artikel
|
| 16 |
NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia
|
Vaz, Karl
|
|
|
18 |
4 |
p. 1135-1143
|
artikel
|
| 17 |
PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study
|
Gao, Hongxiang
|
|
|
18 |
4 |
p. 1326-1335
|
artikel
|
| 18 |
Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis
|
Zhang, Pei-Xin
|
|
|
18 |
4 |
p. 1110-1121
|
artikel
|
| 19 |
Prophylaxis of hepatic encephalopathy: current and future drug targets
|
Maharshi, Sudhir
|
|
|
18 |
4 |
p. 1096-1109
|
artikel
|
| 20 |
Response to the letter of HEPI-D-24–00252
|
Huang, Shang-Chin
|
|
|
18 |
4 |
p. 1340-1341
|
artikel
|
| 21 |
Sleep patterns, genetic susceptibility, and risk of cirrhosis among individuals with nonalcoholic fatty liver disease
|
Qin, Shifan
|
|
|
18 |
4 |
p. 1158-1167
|
artikel
|
| 22 |
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular–cholangiocarcinoma
|
Gong, Wenchen
|
|
|
18 |
4 |
p. 1310-1325
|
artikel
|
| 23 |
The hepatic steatosis, steatohepatitis and metabolic dysfunction: distinct roles in hepatocellular carcinoma occurrence in chronic hepatitis B patients
|
Hu, Xindan
|
|
|
18 |
4 |
p. 1338-1339
|
artikel
|
| 24 |
The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease
|
Wu, Haifeng
|
|
|
18 |
4 |
p. 1144-1157
|
artikel
|
| 25 |
Treating extrahepatic portal-vein obstruction with cavernoma using radiological interventions: pushing the boundaries
|
Mukund, Amar
|
|
|
18 |
4 |
p. 1093-1095
|
artikel
|
Tijdschrift beschrijving